Damora Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Damora Therapeutics announced equity inducement grants to three newly-hired non-executive employees on September 1, 2026. The grants consist of options to purchase 135,400 ordinary shares at $28.18 per share with a 10-year term and standard 4-year vesting schedule. The awards were approved by the Compensation Committee as material inducements for employment.